(Q34622545)

English

Estrogen receptor α and aromatase polymorphisms affect risk, prognosis, and therapeutic outcome in men with castration-resistant prostate cancer treated with docetaxel-based therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Estrogen receptor α and aromatase polymorphisms affect risk, prognosis, and therapeutic outcome in men with castration-resistant prostate cancer treated with docetaxel-based therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

prostate cancer

1 reference

based on heuristic

inferred from title

William Douglas Figg, Sr.

9

object named as

William D Figg

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Tristan M Sissung

1

object named as

Tristan M Sissung

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Romano Danesi

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

C Tyler Kirkland

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Caitlin E Baum

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sandra B Ockers

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Erica V Stein

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

David Venzon

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Douglas K Price

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

24 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

The Journal of Clinical Endocrinology and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

96

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

E368-72

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048329

7 July 2018

The role of oestrogen in the pathogenesis of obesity, type 2 diabetes, breast cancer and prostate disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048329

7 July 2018

CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048329

7 July 2018

CYP1B1 expression is induced by docetaxel: effect on cell viability and drug resistance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048329

7 July 2018

Can a single model explain both breast cancer and prostate cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048329

7 July 2018

Pharmacogenetics and regulation of human cytochrome P450 1B1: implications in hormone-mediated tumor metabolism and a novel target for therapeutic intervention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048329

7 July 2018

A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048329

7 July 2018

Relationships between age-related changes of sex steroids, obesity and body fat distribution among healthy Polish males

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048329

7 July 2018

Hormonal carcinogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048329

7 July 2018

Antagonism between estradiol and progestin on Bcl-2 expression in breast-cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048329

7 July 2018

Single and multigenic analysis of the association between variants in 12 steroid hormone metabolism genes and risk of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048329

26 October 2018

Association between estrogen and androgen receptor genes and prostate cancer risk.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048329

26 October 2018

Association of the CYP1B1*3 allele with survival in patients with prostate cancer receiving docetaxel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048329

26 October 2018

Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048329

26 October 2018

Evaluation of Genetic Variations in the Androgen and Estrogen Metabolic Pathways as Risk Factors for Sporadic and Familial Prostate Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048329

9 December 2018

Phytoestrogen Exposure, Polymorphisms in COMT, CYP19, ESR1, and SHBG Genes, and Their Associations With Prostate Cancer Risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048329

9 December 2018

Bcl2 is the guardian of microtubule integrity

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106711

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pre-clinical and clinical evaluation of estramustine, docetaxel and thalidomide combination in androgen-independent prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106711

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treating prostate cancer: a rationale for targeting local oestrogens

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106711

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1210/JC.2010-2070

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

release_ox6tcdnlvrhkpgtjoninbkdcja

1 reference

https://api.fatcat.wiki/v0/release/ox6tcdnlvrhkpgtjoninbkdcja

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34622545&oldid=1966879520"